Exposure to human pharmaceuticals Carbamazepine, Ibuprofen and Bezafibrate causes molecular effects in Dreissena polymorpha

Aquatic Toxicology

Volumn 105, Issue 3-4, 2011, Pages 428-437

  Contardo Jara, Valeska ^a   Lorenz, Claudia ^a   Pflugmacher, Stephan ^b   Nützmann, Gunnar ^a   Kloas, Werner ^a   Wiegand, Claudia ^c  

^a LEIBNIZ INSTITUTE OF FRESHWATER ECOLOGY AND INLAND FISHERIES   (Germany)

^b TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Bezafibrate; Bioaccumulation; Carbamazepine; Detoxification; Ibuprofen; Invertebrate

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BEZAFIBRATE; CARBAMAZEPINE; CATALASE; GLUTATHIONE TRANSFERASE P1; GLYCOPROTEIN P; HEAT SHOCK PROTEIN 70; IBUPROFEN; MESSENGER RNA; METALLOTHIONEIN; SUPEROXIDE DISMUTASE; SURFACE WATER;

BIOACCUMULATION; BIOMARKER; BIOTRANSFORMATION; CONCENTRATION (COMPOSITION); DETOXIFICATION; DRUG; ENZYME; MOLLUSC; PROTEIN; RNA;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIGESTIVE SYSTEM; DOWN REGULATION; DREISSENA; DREISSENA POLYMORPHA; DRUG DETOXIFICATION; DRUG EXPOSURE; DRUG TISSUE LEVEL; EFFLUENT; ENVIRONMENTAL EXPOSURE; GILL; LONG TERM EXPOSURE; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN PROCESSING; SEWAGE TREATMENT PLANT; TOXICOKINETICS;

ANIMALS; BEZAFIBRATE; BIOLOGICAL MARKERS; BODY BURDEN; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DREISSENA; HSP70 HEAT-SHOCK PROTEINS; IBUPROFEN; METABOLIC DETOXICATION, DRUG; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOXICITY TESTS, CHRONIC; WATER POLLUTANTS, CHEMICAL;

DREISSENA POLYMORPHA; INVERTEBRATA;

EID: 80052035840     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2011.07.017     Document Type: Article

References (44)

1. Abshagen U., Bablok W., Koch K., Lang P.D., Schmidt H.A., Senn M., Stork H. Disposition pharmacokinetics of bezafibrate in man. Eur. J. Clin. Pharmacol. 1979, 16:31-38.
2. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
3. Brown J.N., Paxeus N., Förlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Pharmacol. 2007, 24:267-274.
4. Canesi L., Lorusso L.C., Ciacci C., Betti M., Regoli F., Poiana G., Gallo G., Marcomini A. Effects of blood lipid lowering pharmaceuticals (bezafibrate and gemfibrozil) on immune and digestive gland functions of the bivalve mollusc, Mytilus galloprovincialis. Chemosphere 2007, 69:994-1002.
5. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59:309-315.
6. Contardo-Jara V., Lorenz C., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. Molecular effects and bioaccumulation of levonorgestrel in the non-target organism Dreissena polymorpha. Environ. Pollut. 2011, 159:38-44.
7. Contardo-Jara V., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. The beta-receptor blocker metoprolol alters detoxification processes in the non-target organism Dreissena polymorpha. Environ. Pollut. 2010, 158:2059-2066.
8. Cueva-Mestanza R., Torres-Padrón M.E., Sosa-Ferrera Z., Santana-Rodríguez J.J. Microwave-assisted micellar extraction coupled with solid-phase extraction for preconcentration of pharmaceuticals in molluscs prior to determination by HPLC. Biomed. Chromatogr. 2008, 22:1115-1122.
9. De Lange H.J., Noordoven W., Murk A.J., Lürling M., Peeters E.T. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat. Toxicol. 2006, 78:209-216.
10. Dietrich S., Ploessl F., Bracher F., Laforsch C. Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia magna - a multigenerational study. Chemosphere 2010, 79:60-66.
11. Faria M., Carrasco L., Diez S., Riva M.C., Bayona J.M., Barata C. Multi-biomarker responses in the freshwater mussel Dreissena polymorpha exposed to polychlorobiphenyls and metals. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2009, 149:281-288.
12. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
13. Ferrari B., Paxéus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 2003, 55:359-370.
14. Flippin J.L., Huggett D., Foran C.M. Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquat. Toxicol. 2007, 81:73-78.
15. Frey H.H., Janz D. Antiepileptic Drugs, Handbook of Experimental Pharmacology 1985, vol. 74. Springer Verlag, Berlin, Heidelberg, New York, Tokyo.
16. Gagné F., Bérubé E., Fournier M., Blaise C. Inflammatory properties of municipal effluents to Elliptio complanata mussels - lack of effects from anti-inflammatory drugs. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2005, 141:332-337.
17. Gagné F., Blaise C., André C. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol. Environ. Saf. 2006, 64:329-336.
18. Gravel A., Vijayan M.M. Non-steroidal anti-inflammatory drugs disrupt the heat shock response in rainbow trout. Aquat. Toxicol. 2007, 81:197-206.
19. Hahn M.E. The Ah receptor: a comparative perspective. Comp. Biochem. Physiol. C 1998, 121:23-53.
20. Heberer T., Mechlinski A., Fanck B., Knappe A., Massmann G., Pekdeger A., Fritz B. Field studies on the fate and transport of pharmaceutical residues in bank filtration. Ground Water Monit. Remed. 2004, 24:70-77.
21. Isidori M., Nardelli A., Pascarella L., Rubino M., Parrella A. Toxic and genotoxic impact of fibrates and their photoproducts on non-target organisms. Environ. Int. 2007, 33:635-641.
22. Kuehl G.E., Lampe J.W., Potter J.D., Bigler J. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab. Dispos. 2005, 33:1027-1035.
23. Kümmerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J. Environ. Manage. 2009, 90:2354-2366.
24. Kümmerer K. Pharmaceuticals in the environment. A brief summary. Pharmaceuticals in the Environment 2010, 3-17. Springer Verlag, Berlin. K. Kümmerer (Ed.).
25. Laville N., Aït-Aïssa S., Gomez E., Casellas C., Porcher J.M. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196:41-55.
26. Le Curieux-Belfond O., Fievet B., Séralini G.E., Mathieu M. Short-term bioaccumulation, circulation and metabolism of estradiol-17β in the oyster Crassostrea gigas. J. Exp. Mar. Biol. Ecol. 2005, 325:125-133.
27. Lewis S., Handy R.D., Cordi B., Billinghurst Z., Depledge M.H. Stress proteins (HSP's): methods of detection and their use as an environmental biomarker. Ecotoxicology 1999, 8:351-368.
28. Li Z.H., Velisek J., Zlabek V., Grabic R., Machova J., Kolarova J., Randak T. Hepatic antioxidant status and hematological parameters in rainbow trout, Oncorhynchus mykiss, after chronic exposure to carbamazepine. Chem. Biol. Interact. 2010, 183:98-104.
29. Martin-Diaz M.L., Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. Effects of environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 2009, 94:177-185.
30. Martin-Diaz M.L., Gagne F., Blaise C. The use of biochemical responses to assess ecotoxicological effects of pharmaceutical and personal care products (PPCPs) after injection in the mussel Elliptio complanata. Environ. Toxicol. Pharmacol. 2009, 28:237-242.
31. Pain S., Parant M. Multixenobiotic defense mechanism (MDMX) in bivalves. C. R. Biol. 2003, 326:659-672.
32. Quinn B., Gagné F., Blaise C. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata. Sci. Total Environ. 2008, 389:306-314.
33. Quinn B., Gagné F., Costello M., McKenzie C., Wilson J., Mothersill C. The endocrine disrupting effect of municipal effluent on the zebra mussel (Dreissena polymorpha). Aquat. Toxicol. 2004, 66:279-292.
34. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ. Toxicol. Chem. 2009, 28:2587-2597.
35. Rosal R., Rodea-Palomares I., Boltes K., Fernández-Piñas F., Leganés F., Gonzalo S., Petre A. Ecotoxicity assessment of lipid regulators in water and biologically treated wastewater using three aquatic organisms. Environ. Sci. Pollut. Res. Int. 2010, 17:135-144.
36. Sacher F., Ehmann M., Gabriel S., Graf C., Brauch H.J. Pharmaceutical residues in the river Rhine - results of a one-decade monitoring programme. J. Environ. Monit. 2008, 10:664-670.
37. Santos J.L., Aparicio I., Callejón M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J. Hazard. Mater. 2009, 164:1509-1516.
38. Sheehan D., Meade G., Foley V.M., Dowd C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 2001, 360:1-16.
39. Smital T., Sauerborn R., Hackenberger B.K. Inducibility of the P-glycoprotein transport activity in the marine mussel Mytilus galloprovincialis and the freshwater mussel Dreissena polymorpha. Aquat. Toxicol. 2003, 65:443-465.
40. Staines A.G., Coughtrie M.W.H., Burchell B. N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7. J. Pharmacol. Exp. Ther. 2004, 311:1131-1137.
41. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro. Brazil. Sci. Total Environ. 1999, 225:135-141.
42. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
43. Weston A., Caminada D., Galicia H., Fent K. Effects of lipid-lowering pharmaceuticals bezafibrate and clofibric acid on lipid metabolism in fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 2009, 28:2648-2655.
44. Wiegel S., Aulinger A., Brockmeyer R., Harms H., Löffler J., Reincke H., Schmidt R., Stachel B., von Tümpling W., Wanke A. Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 2004, 57:107-126.